| 1 |
35409418 | BRCA2 C-Terminal RAD51-Binding Domain Confers Resistance to DNA-Damaging Agents. | 2022 Apr 6 |
2 |
| 2 |
34091215 | Combined modality therapy including cytoreductive surgery and heated intraperitoneal chemotherapy for synchronous low volume peritoneal carcinomatosis from adenocarcinoma of the tail of pancreas in a BRCA-2 carrier resulting in long-term disease-free survival: A case report. | 2021 Jun |
1 |
| 3 |
22579622 | High levels of wild-type BRCA2 suppress homologous recombination. | 2012 Aug 3 |
1 |
| 4 |
20625817 | Ionizing radiation or mitomycin-induced micronuclei in lymphocytes of BRCA1 or BRCA2 mutation carriers. | 2011 Jun |
3 |
| 5 |
20174566 | Use of DNA-damaging agents and RNA pooling to assess expression profiles associated with BRCA1 and BRCA2 mutation status in familial breast cancer patients. | 2010 Feb 19 |
2 |
| 6 |
20442529 | Mitomycin-induced interstitial pneumonitis in a patient with BRCA2 associated metastatic pancreatic carcinoma. | 2010 May 5 |
1 |
| 7 |
19433978 | Prolonged survival in a patient with BRCA2 associated metastatic pancreatic cancer after exposure to camptothecin: a case report and review of literature. | 2009 Aug |
2 |
| 8 |
19584259 | PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2. | 2009 Jul |
1 |
| 9 |
18469443 | Response to a third-line mitomycin C (MMC)-based chemotherapy in a patient with metastatic pancreatic adenocarcinoma carrying germline BRCA2 mutation. | 2008 May 8 |
3 |
| 10 |
18593900 | A syngeneic variance library for functional annotation of human variation: application to BRCA2. | 2008 Jul 1 |
5 |
| 11 |
16648548 | Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer. | 2006 Apr |
1 |
| 12 |
16687415 | Functional interplay between BRCA2/FancD1 and FancC in DNA repair. | 2006 Jul 28 |
1 |
| 13 |
16920162 | Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2. | 2006 Oct 10 |
5 |
| 14 |
17106252 | Altered expression of FANCL confers mitomycin C sensitivity in Calu-6 lung cancer cells. | 2006 Dec |
2 |
| 15 |
15671039 | Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage. | 2005 Apr 15 |
6 |
| 16 |
15314155 | BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage. | 2004 Sep |
2 |
| 17 |
12591928 | p53 mediates repression of the BRCA2 promoter and down-regulation of BRCA2 mRNA and protein levels in response to DNA damage. | 2003 May 2 |
1 |
| 18 |
12915460 | Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. | 2003 Oct 1 |
1 |
| 19 |
12065746 | Biallelic inactivation of BRCA2 in Fanconi anemia. | 2002 Jul 26 |
2 |
| 20 |
11532935 | Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences. | 2001 Sep 3 |
1 |